Nasdaq: PRLD
Prelude Therapeutics insiders
The officers, directors and 10% owners of Prelude Therapeutics Incorporated who hold the most stock, valued at the live PRLD price.
$3.26
PRLD today −$45K (−1.36%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 1
- Their PRLD stock
- $9.7M
- Market value
- $261M
- Held by ranked insiders
- 3.72%
Insiders by value of PRLD holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Krishna Vaddi | CEO | 2,974,725 | $9.7M | 3.72% | 8992nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Prelude Therapeutics; see each profile for the filing.